In March 2025, the company introduced new strategies for the direct-to-shopper supplying of its Wegovy weight loss drug. The company founded a different pharmacy, termed NovoCare, which would demand shoppers $499 monthly for usage of the drug, less than 50 percent the expense of the drug by way of other pharmaceutical distribution networks.[53]Inco